Kewaunee Scientific Corporation cash flow to debt ratio of 61.73% indicates that the company generates enough cash to cover its debts. This level indicates strong financial health.

Kewaunee Scientific Corporation's free cash flow has increased 16.48% from $12.62M last year to $14.70M, signaling increasing performance

Kewaunee Scientific Corporation's debt to equity ratio is 0.40, which means that the company's assets are healthy financed, signaling financial stability.

Kewaunee Scientific Corporation's debt has decreased relative to shareholder equity from 0.78 last year to 0.40 today, signaling strengthened financials

Kewaunee Scientific Corporation has a net debt to EBITDA ratio of 0.78x, which is below the 3.00x threshold, indicating healthy leverage and financial stability

Kewaunee Scientific Corporation's interest coverage ratio of 4.33 indicates that earnings with good margin can cover interest payments on company debt

Kewaunee Scientific Corporation's profit margin has decreased (28.09%) in the last year from 4.74% to 3.41%, signaling decreasing performance

Kewaunee Scientific Corporation's short-term assets of $105.40M exceed its short-term liabilities of $48.35M

Kewaunee Scientific Corporation's return on assets of 5.39% is higher than the 5.00% threshold, indicating efficient asset utilization

Kewaunee Scientific Corporation's return on equity of 13.63%, is lower than 15.00%, indicating bad performance

Kewaunee Scientific Corporation's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

Kewaunee Scientific Corporation had positive net income in 4 out of 5 years, indicating stable and consistent earnings

Kewaunee Scientific Corporation has positive free cash flow, indicating the company generates cash after capital expenditures

Kewaunee Scientific Corporation has a free cash flow yield of 14.07%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

Kewaunee Scientific Corporation's yearly earnings has decreased 15.67% since last year from $11.40M to $9.62M, signaling decreasing performance

Kewaunee Scientific Corporation's yearly revenue has increased 17.27% since last year from $240.47M to $282.00M, signaling increasing performance

ROIC 9.18% (Source: FMP key-metrics). In the 5–10% partial-credit band. Score: 1 of 2. This band sits within the typical US weighted-average cost of capital range. Methodology choice can change the conclusion: under FMP's invested-capital definition the company is at or near its cost of capital; under narrower operating-capital definitions the same company may score higher. Invested capital here includes equity, non-current liabilities, and short-term debt. Cash is not subtracted. See methodology.

Kewaunee Scientific Corporation's 3-year revenue CAGR of 8.71% is positive, indicating growing revenue over the past 3 years

Kewaunee Scientific Corporation had revenue growth in 4 out of 5 years, indicating consistent revenue performance

Kewaunee Scientific Corporation had positive ROE in 4 out of 5 years, indicating consistent and reliable returns on equity

Kewaunee Scientific Corporation is undervalued relative to its fair value price of 65.85 based on Discounted Cash Flow model

Kewaunee Scientific Corporation has an earnings yield of 9.22%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings

Kewaunee Scientific Corporation is undervalued relative to its fair value price of 43.30 based on EBITDA multiple model

Kewaunee Scientific Corporation has an EV/EBITDA ratio of 5.15x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

Kewaunee Scientific Corporation is undervalued relative to its fair value price of 111.49 based on Earnings Fair Value model

Kewaunee Scientific Corporation had non-positive diluted EPS five years ago; the PEG ratio is not meaningful and the check fails.

Kewaunee Scientific Corporation has a price-to-book ratio of 1.36x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Kewaunee Scientific Corporation has a price-to-sales ratio of 0.37x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue